Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 979 entries
Sorted by: Best Match Show Resources per page
Trifluoroethoxy-Coated Subphthalocyanine affects Trifluoromethylation of Alkenes and Alkynes even under Low-Energy Red-Light Irradiation.

ChemistryOpen

Matsuzaki K, Hiromura T, Tokunaga E, Shibata N.
PMID: 28413756
ChemistryOpen. 2017 Feb 21;6(2):226-230. doi: 10.1002/open.201600172. eCollection 2017 Apr.

Photoredox chemical reactions induced by visible light have undergone a renaissance in recent years. Polypyridyl dyes such as Ir(ppy)

Cite
Matsuzaki K, Hiromura T, Tokunaga E, et al. Trifluoroethoxy-Coated Subphthalocyanine affects Trifluoromethylation of Alkenes and Alkynes even under Low-Energy Red-Light Irradiation. ChemistryOpen. 2017;6(2):226-230doi: 10.1002/open.201600172.
Matsuzaki, K., Hiromura, T., Tokunaga, E., & Shibata, N. (2017). Trifluoroethoxy-Coated Subphthalocyanine affects Trifluoromethylation of Alkenes and Alkynes even under Low-Energy Red-Light Irradiation. ChemistryOpen, 6(2), 226-230. https://doi.org/10.1002/open.201600172
Matsuzaki, Kohei, et al. "Trifluoroethoxy-Coated Subphthalocyanine affects Trifluoromethylation of Alkenes and Alkynes even under Low-Energy Red-Light Irradiation." ChemistryOpen vol. 6,2 (2017): 226-230. doi: https://doi.org/10.1002/open.201600172
Matsuzaki K, Hiromura T, Tokunaga E, Shibata N. Trifluoroethoxy-Coated Subphthalocyanine affects Trifluoromethylation of Alkenes and Alkynes even under Low-Energy Red-Light Irradiation. ChemistryOpen. 2017 Feb 21;6(2):226-230. doi: 10.1002/open.201600172. eCollection 2017 Apr. PMID: 28413756; PMCID: PMC5390801.
Copy Download .nbib Format: NLM
IF.

Chemical communications (Cambridge, England)

Cui B, Kosobokov M, Matsuzaki K, Tokunaga E, Shibata N.
PMID: 28513647
Chem Commun (Camb). 2017 May 30;53(44):5997-6000. doi: 10.1039/c7cc02802d.

A difficult chlorine-fluorine (Cl-F) exchange fluorination reaction in the final stage of the preparation of pentafluoro-λ

Cite
Cui B, Kosobokov M, Matsuzaki K, et al. IF. Chem Commun (Camb). 2017;53(44):5997-6000doi: 10.1039/c7cc02802d.
Cui, B., Kosobokov, M., Matsuzaki, K., Tokunaga, E., & Shibata, N. (2017). IF. Chemical communications (Cambridge, England), 53(44), 5997-6000. https://doi.org/10.1039/c7cc02802d
Cui, Benqiang, et al. "IF." Chemical communications (Cambridge, England) vol. 53,44 (2017): 5997-6000. doi: https://doi.org/10.1039/c7cc02802d
Cui B, Kosobokov M, Matsuzaki K, Tokunaga E, Shibata N. IF. Chem Commun (Camb). 2017 May 30;53(44):5997-6000. doi: 10.1039/c7cc02802d. PMID: 28513647.
Copy Download .nbib Format: NLM
Influence of regular exercise on gastric emptying in healthy men: a pilot study.

Journal of clinical biochemistry and nutrition

Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T.
PMID: 27698540
J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16.

Functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD), are common chronic disorders even in the younger population. Physical activity is advocated for patients with FGIDs, although the evidence is insufficient. We investigated the association between the intensity of regular...

Cite
Matsuzaki J, Suzuki H, Masaoka T, et al. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016;59(2):130-133doi: 10.3164/jcbn.16-29.
Matsuzaki, J., Suzuki, H., Masaoka, T., Tanaka, K., Mori, H., & Kanai, T. (2016). Influence of regular exercise on gastric emptying in healthy men: a pilot study. Journal of clinical biochemistry and nutrition, 59(2), 130-133. https://doi.org/10.3164/jcbn.16-29
Matsuzaki, Juntaro, et al. "Influence of regular exercise on gastric emptying in healthy men: a pilot study." Journal of clinical biochemistry and nutrition vol. 59,2 (2016): 130-133. doi: https://doi.org/10.3164/jcbn.16-29
Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16. PMID: 27698540; PMCID: PMC5018576.
Copy Download .nbib Format: NLM
Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report.

Oncology letters

Yamaguchi T, Seki T, Miyasaka C, Inokuchi R, Kawamura R, Sakaguchi Y, Murata M, Matsuzaki K, Nakano Y, Uemura Y, Okazaki K.
PMID: 25789013
Oncol Lett. 2015 Apr;9(4):1633-1636. doi: 10.3892/ol.2015.2934. Epub 2015 Feb 05.

Sorafenib is a multikinase inhibitor currently approved in Japan for the treatment of unresectable hepatocellular carcinoma. Interstitial pneumonia induced by sorafenib may have a fatal outcome, and therefore, has recently been the focus of many studies. The current report...

Cite
Yamaguchi T, Seki T, Miyasaka C, et al. Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncol Lett. 2015;9(4):1633-1636doi: 10.3892/ol.2015.2934.
Yamaguchi, T., Seki, T., Miyasaka, C., Inokuchi, R., Kawamura, R., Sakaguchi, Y., Murata, M., Matsuzaki, K., Nakano, Y., Uemura, Y., & Okazaki, K. (2015). Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncology letters, 9(4), 1633-1636. https://doi.org/10.3892/ol.2015.2934
Yamaguchi, Takashi, et al. "Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report." Oncology letters vol. 9,4 (2015): 1633-1636. doi: https://doi.org/10.3892/ol.2015.2934
Yamaguchi T, Seki T, Miyasaka C, Inokuchi R, Kawamura R, Sakaguchi Y, Murata M, Matsuzaki K, Nakano Y, Uemura Y, Okazaki K. Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report. Oncol Lett. 2015 Apr;9(4):1633-1636. doi: 10.3892/ol.2015.2934. Epub 2015 Feb 05. PMID: 25789013; PMCID: PMC4356407.
Copy Download .nbib Format: NLM
Differences in Cartilage Repair between Loading and Unloading Environments in the Rat Knee.

Journal of the Japanese Physical Therapy Association = Rigaku ryoho

Takahashi I, Matsuzaki T, Yoshida S, Kitade I, Hoso M.
PMID: 25792905
J Jpn Phys Ther Assoc. 2014;17(1):22-30. doi: 10.1298/jjpta.Vol17_004.

We investigated the histopathological and immunohistochemical effects of loading on cartilage repair in rat full-thickness articular cartilage defects. A total of 40 male 9-week-old Wistar rats were studied. Full-thickness articular cartilage defects were created over the capsule at the...

Cite
Takahashi I, Matsuzaki T, Yoshida S, et al. Differences in Cartilage Repair between Loading and Unloading Environments in the Rat Knee. J Jpn Phys Ther Assoc. 2014;17(1):22-30doi: 10.1298/jjpta.Vol17_004.
Takahashi, I., Matsuzaki, T., Yoshida, S., Kitade, I., & Hoso, M. (2014). Differences in Cartilage Repair between Loading and Unloading Environments in the Rat Knee. Journal of the Japanese Physical Therapy Association = Rigaku ryoho, 17(1), 22-30. https://doi.org/10.1298/jjpta.Vol17_004
Takahashi, Ikufumi, et al. "Differences in Cartilage Repair between Loading and Unloading Environments in the Rat Knee." Journal of the Japanese Physical Therapy Association = Rigaku ryoho vol. 17,1 (2014): 22-30. doi: https://doi.org/10.1298/jjpta.Vol17_004
Takahashi I, Matsuzaki T, Yoshida S, Kitade I, Hoso M. Differences in Cartilage Repair between Loading and Unloading Environments in the Rat Knee. J Jpn Phys Ther Assoc. 2014;17(1):22-30. doi: 10.1298/jjpta.Vol17_004. PMID: 25792905; PMCID: PMC4316548.
Copy Download .nbib Format: NLM
SF.

Chemical communications (Cambridge, England)

Das P, Takada M, Matsuzaki K, Saito N, Shibata N.
PMID: 28317050
Chem Commun (Camb). 2017 Mar 30;53(27):3850-3853. doi: 10.1039/c7cc01043e.

Electrophilic pentafluorosulfanyl (SF

Cite
Das P, Takada M, Matsuzaki K, et al. SF. Chem Commun (Camb). 2017;53(27):3850-3853doi: 10.1039/c7cc01043e.
Das, P., Takada, M., Matsuzaki, K., Saito, N., & Shibata, N. (2017). SF. Chemical communications (Cambridge, England), 53(27), 3850-3853. https://doi.org/10.1039/c7cc01043e
Das, Prajwalita, et al. "SF." Chemical communications (Cambridge, England) vol. 53,27 (2017): 3850-3853. doi: https://doi.org/10.1039/c7cc01043e
Das P, Takada M, Matsuzaki K, Saito N, Shibata N. SF. Chem Commun (Camb). 2017 Mar 30;53(27):3850-3853. doi: 10.1039/c7cc01043e. PMID: 28317050.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing.

Biochemistry and biophysics reports

Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S.
PMID: 29124162
Biochem Biophys Rep. 2015 Jul 08;3:1-6. doi: 10.1016/j.bbrep.2015.07.001. eCollection 2015 Sep.

CM2 is an integral membrane protein encoded by the influenza C virus M gene. To examine the effects of the cytoplasmic tail of CM2 on its biochemical properties, deletion and substitution mutations were introduced into CM2 cytoplasmic tail at...

Cite
Shimotai Y, Goto T, Matsuzaki Y, et al. The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochem Biophys Rep. 2015;3:1-6doi: 10.1016/j.bbrep.2015.07.001.
Shimotai, Y., Goto, T., Matsuzaki, Y., Muraki, Y., Sugawara, K., & Hongo, S. (2015). The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochemistry and biophysics reports, 31-6. https://doi.org/10.1016/j.bbrep.2015.07.001
Shimotai, Yoshitaka, et al. "The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing." Biochemistry and biophysics reports vol. 3 (2015): 1-6. doi: https://doi.org/10.1016/j.bbrep.2015.07.001
Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S. The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochem Biophys Rep. 2015 Jul 08;3:1-6. doi: 10.1016/j.bbrep.2015.07.001. eCollection 2015 Sep. PMID: 29124162; PMCID: PMC5668659.
Copy Download .nbib Format: NLM
Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis.

Journal of clinical biochemistry and nutrition

Shimizu Y, Dobashi K, Nagase H, Ohta K, Sano T, Matsuzaki S, Ishii Y, Satoh T, Koka M, Yokoyama A, Ohkubo T, Ishii Y, Kamiya T.
PMID: 25834305
J Clin Biochem Nutr. 2015 Jan;56(1):74-83. doi: 10.3164/jcbn.14-44. Epub 2014 Nov 28.

The cellular mechanisms involved in the development of silicosis have not been fully elucidated. This study aimed to examine influence of silica-induced lung injury on autophagy. Suspensions of crystalline silica particles were administered transnasally to C57BL/6j mice. Immunohistochemical examination...

Cite
Shimizu Y, Dobashi K, Nagase H, et al. Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. J Clin Biochem Nutr. 2014;56(1):74-83doi: 10.3164/jcbn.14-44.
Shimizu, Y., Dobashi, K., Nagase, H., Ohta, K., Sano, T., Matsuzaki, S., Ishii, Y., Satoh, T., Koka, M., Yokoyama, A., Ohkubo, T., Ishii, Y., & Kamiya, T. (2015). Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. Journal of clinical biochemistry and nutrition, 56(1), 74-83. https://doi.org/10.3164/jcbn.14-44
Shimizu, Yasuo, et al. "Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis." Journal of clinical biochemistry and nutrition vol. 56,1 (2015): 74-83. doi: https://doi.org/10.3164/jcbn.14-44
Shimizu Y, Dobashi K, Nagase H, Ohta K, Sano T, Matsuzaki S, Ishii Y, Satoh T, Koka M, Yokoyama A, Ohkubo T, Ishii Y, Kamiya T. Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis. J Clin Biochem Nutr. 2015 Jan;56(1):74-83. doi: 10.3164/jcbn.14-44. Epub 2014 Nov 28. PMID: 25834305; PMCID: PMC4306660.
Copy Download .nbib Format: NLM
Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan.

United European gastroenterology journal

Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T.
PMID: 24917957
United European Gastroenterol J. 2013 Jun;1(3):175-83. doi: 10.1177/2050640613485238.

BACKGROUND: The GerdQ scoring system may be a useful tool for managing gastro-oesophageal reflux disease. However, GerdQ has not been fully validated in Asian countries.OBJECTIVE: To validate the Japanese version of GerdQ and to compare this version to the...

Cite
Suzuki H, Matsuzaki J, Okada S, et al. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J. 2013;1(3):175-83doi: 10.1177/2050640613485238.
Suzuki, H., Matsuzaki, J., Okada, S., Hirata, K., Fukuhara, S., & Hibi, T. (2013). Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European gastroenterology journal, 1(3), 175-83. https://doi.org/10.1177/2050640613485238
Suzuki, Hidekazu, et al. "Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan." United European gastroenterology journal vol. 1,3 (2013): 175-83. doi: https://doi.org/10.1177/2050640613485238
Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J. 2013 Jun;1(3):175-83. doi: 10.1177/2050640613485238. PMID: 24917957; PMCID: PMC4040759.
Copy Download .nbib Format: NLM
Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Matsusaka S, Nashimoto A, Nishikawa K, Miki A, Miwa H, Yamaguchi K, Yoshikawa T, Ochiai A, Morita S, Sano T, Kodera Y, Kakeji Y, Sakamoto J, Saji S, Yoshida K.
PMID: 26621522
Gastric Cancer. 2016 Jul;19(3):1026. doi: 10.1007/s10120-015-0576-y.

No abstract available.

Cite
Matsusaka S, Nashimoto A, Nishikawa K, et al. Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Gastric Cancer. 2016;19(3):1026doi: 10.1007/s10120-015-0576-y.
Matsusaka, S., Nashimoto, A., Nishikawa, K., Miki, A., Miwa, H., Yamaguchi, K., Yoshikawa, T., Ochiai, A., Morita, S., Sano, T., Kodera, Y., Kakeji, Y., Sakamoto, J., Saji, S., & Yoshida, K. (2016). Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 19(3), 1026. https://doi.org/10.1007/s10120-015-0576-y
Matsusaka, Satoshi, et al. "Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 19,3 (2016): 1026. doi: https://doi.org/10.1007/s10120-015-0576-y
Matsusaka S, Nashimoto A, Nishikawa K, Miki A, Miwa H, Yamaguchi K, Yoshikawa T, Ochiai A, Morita S, Sano T, Kodera Y, Kakeji Y, Sakamoto J, Saji S, Yoshida K. Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Gastric Cancer. 2016 Jul;19(3):1026. doi: 10.1007/s10120-015-0576-y. PMID: 26621522; PMCID: PMC4969921.
Copy Download .nbib Format: NLM
Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART).

SpringerPlus

Kimura Y, Harada Y, Yasuda N, Ishidao T, Yusa S, Matsusaki K, Yonemitsu Y.
PMID: 26702369
Springerplus. 2015 Dec 17;4:780. doi: 10.1186/s40064-015-1508-3. eCollection 2015.

For the production of tumor-specific vaccines, including dendritic cell (DC) vaccines, the tumor cells themselves are an ideal source. Floating tumor cells in the ascites fluid from patients with malignant ascites are a good candidate source, but it is...

Cite
Kimura Y, Harada Y, Yasuda N, et al. Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART). Springerplus. 2015;4:780doi: 10.1186/s40064-015-1508-3.
Kimura, Y., Harada, Y., Yasuda, N., Ishidao, T., Yusa, S., Matsusaki, K., & Yonemitsu, Y. (2015). Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART). SpringerPlus, 4780. https://doi.org/10.1186/s40064-015-1508-3
Kimura, Yukino, et al. "Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART)." SpringerPlus vol. 4 (2015): 780. doi: https://doi.org/10.1186/s40064-015-1508-3
Kimura Y, Harada Y, Yasuda N, Ishidao T, Yusa S, Matsusaki K, Yonemitsu Y. Effective recovery of highly purified CD326(+) tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART). Springerplus. 2015 Dec 17;4:780. doi: 10.1186/s40064-015-1508-3. eCollection 2015. PMID: 26702369; PMCID: PMC4683161.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 979 entries